ERBB2 and breast cancer: In HER2-enriched breast cancer, 37.7% (n = 210) of the 62.7% (n = 349) of prognostic genes that were adverse were related to extracellular matrix functions, such as “Extracellular matrix organization” and “Integrin signaling pathway” (Supplementary Fig. 10A, lower right).